Latest News and Press Releases
Want to stay updated on the latest news?
-
SANTA CLARA, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- AMD (NASDAQ:AMD) today announced financial results for the first quarter of 2025. First quarter revenue was $7.4 billion, gross margin was 50%,...
-
GAL-101 well tolerated; excellent safety and pharmacokinetic profile strongly supports oral administrationNext arms of study, including multiple ascending dose (MAD), underway and expected to complete...
-
APOLLO BEACH, Fla., May 05, 2025 (GLOBE NEWSWIRE) -- RetinalGenix Technologies, Inc. (OTCQB:RTGN) (“RetinalGenix” or the “Company”), announced today a new laboratory lease agreement with life...
-
Chengdu Origen and Vanotech Announce First Patient Dosed in VAN-2401 Phase 1 Trial of Gene Therapy for Wet Age-Related Macular Degeneration
-
— New instances provide enterprises with high-performance, scalable, and cost-effective cloud computing solutions — SANTA CLARA, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Today, AMD (NASDAQ:...
-
SANTA CLARA, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Today, AMD (NASDAQ: AMD) announced “Advancing AI 2025,” an in-person and livestreamed event on June 12, 2025. The industry event will showcase...
-
SANTA CLARA, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) announced today that it will report fiscal first quarter 2025 financial results on Tuesday, May 6, 2025, after the close of...
-
— Leading cloud services providers expand their adoption of EPYC CPUs to meet growing public cloud demand — SANTA CLARA, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Today, AMD (NASDAQ: AMD)...
-
RetinalGenix Technologies to Participate at 2025 Roth Conference and will discuss patented remote monitoring high-resolution retinal imaging and biomarkers
-
RETINALGENIX TECHNOLOGIES BREAKTHROUGH IN REAL-TIME 24/7 REMOTE OCULAR MONITORING High-Resolution Retinal Imaging Using Both Near Infrared And Green Modes